NCT02153359

Brief Summary

This study is about asthma and how the environment affects asthma. Scientists know that air pollution (such as cigarette smoke and other particles in the air) can make asthma symptoms worse. This research is being done to study how the health of a person with asthma responds to an air cleaner. The investigator hypothesize that an air cleaner will improve the health of persons with asthma.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
23

participants targeted

Target at below P25 for not_applicable asthma

Timeline
Completed

Started Feb 2014

Longer than P75 for not_applicable asthma

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2014

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

April 21, 2014

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 3, 2014

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 11, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 11, 2018

Completed
1 year until next milestone

Results Posted

Study results publicly available

September 12, 2019

Completed
Last Updated

September 12, 2019

Status Verified

August 1, 2019

Enrollment Period

4.6 years

First QC Date

April 21, 2014

Results QC Date

August 20, 2019

Last Update Submit

August 20, 2019

Conditions

Keywords

asthmaHEPAair pollutantslung functionhome environmentrespiratory symptoms

Outcome Measures

Primary Outcomes (2)

  • PM2.5 Concentration (ug/m^3)

    Fine particulate matter (PM2.5) concentration as assessed by a passive filter placed in the participant's home.

    Approximately 1 month

  • PM2.5-10 Concentration (ug/m^3)

    Coarse particulate matter (PM2.5-10) concentration as assessed by a passive filter placed in the participant's home.

    Approximately 1 month

Secondary Outcomes (13)

  • Number of Symptom-free Days

    7 days

  • Number of Days With Activity Limitations

    7 days

  • Number of Nights Disrupted by Asthma Symptoms

    7 nights

  • Number of Days of School/Work Missed Due to Asthma Symptoms

    7 days

  • Number of Days of Unscheduled Visits to the Doctor Due to Asthma Symptoms

    7 days

  • +8 more secondary outcomes

Study Arms (2)

Air cleaner then sham air cleaner

EXPERIMENTAL

A High Efficiency Particulate Air Cleaner (HEPA) intervention will be placed in the participant's home for one month. During the last week of the month, health assessments will be conducted, which include in-home health questionnaires, symptom-, and activity- diaries/recalls, blood, and hand-held spirometry. Participants will also be asked to wear a light backpack with air monitoring devices during the course of the day during the last week in order to measure participants' exposures to pollutants. Finally, at the end of the month, participants will be asked to report to the Johns Hopkins outpatient endoscopy suite for bronchoscopy, during which airway sampling will occur under conscious sedation. For the participants who started in the experimental arm, after this one month intervention period, they will then enter a wash-out period where no intervention or outcome measures are undertaken for at least one month prior to cross-over to the sham comparator arm.

Device: High Efficiency Particulate Air CleanerDevice: Sham air cleaner

Sham air cleaner then air cleaner

SHAM COMPARATOR

A sham air cleaner will be placed in the participant's home for one month. During the last week of the month, health assessments will be conducted, which include in-home health questionnaires, symptom-, and activity- diaries/recalls, blood, and hand-held spirometry. Participants will also be asked to wear a light backpack with air monitoring devices during the course of the day during the last week in order to measure participants' exposures to pollutants. Finally, at the end of the month, participants will be asked to report to the Johns Hopkins outpatient endoscopy suite for bronchoscopy, during which airway sampling will occur under conscious sedation. For the participants who started in the sham comparator arm, after this one month intervention period, they will then enter a wash-out period where no intervention or outcome measures are undertaken for at least one month prior to cross-over to the experimental arm.

Device: High Efficiency Particulate Air CleanerDevice: Sham air cleaner

Interventions

Air cleaner then sham air cleanerSham air cleaner then air cleaner
Air cleaner then sham air cleanerSham air cleaner then air cleaner

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age 18-50 years of age
  • Non-smoker (\<100 cigarettes in lifetime)
  • Physician diagnosis of asthma
  • Symptoms of asthma and/or reliever medication use in the past 6 months
  • Living in the current residence \>= 6 months within Baltimore
  • Enrollment in, and completion of, the observational environmental asthma study "Inhale 1"

You may not qualify if:

  • Current diagnosis of another major pulmonary disease, other significant morbidity
  • Pregnancy (as defined by a positive urine pregnancy test at screening of all women of child-bearing potential)
  • Planning to relocate residence or activity that necessitates travel away from home for prolonged period of time during the study period
  • Current use of an air cleaner in the home

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Johns Hopkins Bayview Medical Center

Baltimore, Maryland, 21224, United States

Location

Johns Hopkins Hospital

Baltimore, Maryland, 21287, United States

Location

MeSH Terms

Conditions

AsthmaSigns and Symptoms, Respiratory

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Dr. Sonali Bose
Organization
Johns Hopkins University

Study Officials

  • Sonali Bose, MD MPH

    Johns Hopkins University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 21, 2014

First Posted

June 3, 2014

Study Start

February 1, 2014

Primary Completion

September 11, 2018

Study Completion

September 11, 2018

Last Updated

September 12, 2019

Results First Posted

September 12, 2019

Record last verified: 2019-08

Locations